BioStem Technologies, Inc.
BSEM
$12.91
$3.6038.67%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 82.56M | 74.49M | 41.90M | 11.44M | 3.50M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 82.56M | 74.49M | 41.90M | 11.44M | 3.50M |
| Cost of Revenue | 4.24M | 3.75M | 2.22M | 646.10K | 325.10K |
| Gross Profit | 78.32M | 70.74M | 39.68M | 10.80M | 3.17M |
| SG&A Expenses | 68.49M | 61.79M | 34.95M | 12.51M | 3.70M |
| Depreciation & Amortization | 56.80K | 54.10K | 53.70K | 54.60K | 56.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 73.26M | 65.67M | 37.30M | 13.55M | 4.12M |
| Operating Income | 9.29M | 8.82M | 4.61M | -2.11M | -617.20K |
| Income Before Tax | 9.15M | 8.68M | 4.44M | -2.74M | -1.54M |
| Income Tax Expenses | 2.33M | 2.31M | 1.18M | -- | -- |
| Earnings from Continuing Operations | 6.82M | 6.36M | 3.26M | -2.74M | -1.54M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 6.82M | 6.36M | 3.26M | -2.74M | -1.54M |
| EBIT | 9.29M | 8.82M | 4.61M | -2.11M | -617.20K |
| EBITDA | 9.35M | 8.87M | 4.66M | -2.05M | -567.70K |
| EPS Basic | 0.42 | 0.39 | 0.20 | -0.18 | -0.11 |
| Normalized Basic EPS | 0.35 | 0.33 | 0.17 | -0.08 | -0.04 |
| EPS Diluted | 0.32 | 0.30 | 0.14 | -0.18 | -0.11 |
| Normalized Diluted EPS | 0.27 | 0.25 | 0.12 | -0.08 | -0.04 |
| Average Basic Shares Outstanding | 16.32M | 16.30M | 16.32M | 15.20M | 13.50M |
| Average Diluted Shares Outstanding | 21.13M | 21.35M | 23.42M | 15.20M | 13.50M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
